Synonyms
Definition and Medical Uses
Carbonic anhydrase inhibitor often used in treatment of glaucoma, altitude sickness, and epileptic seizures are the main story for the treatment of pseudotumour cerebri (idiopathic intracranial hypertension).
Use and Dose in Pseudotumor Cerebri
Carbonic anhydrase inhibitors are a first-line treatment and are believed to reduce the level of cerebrospinal fluid production as the mechanism at decreased intracranial pressure. A large multicenter trial, the idiopathic intracranial hypertension trial (IIHT), has supported the use of diet and acetazolamide in IIH. In adult patients, 500 mg twice per day is typically prescribed and advanced as required and tolerated by the patient. In young children, the recommended starting dose is typically 15 mg/kg per day up to 25 mg/kg per day with a maximum dose of 100 mg/kg per day or 2 g per day, but these higher doses are often not tolerated well.
Contraindication
Hyperchloremic acidosis, hypokalemia,...
Further Reading
Pomeranz HD (1999) Weight loss, acetazolamide, and pseudotumor cerebri. Ophthalmology 106(9):1639
Matthews YY (2008) Drugs used in childhood idiopathic or benign intracranial hypertension. Arch Dis Child Educ Pract Ed 93(1):19
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg (outside the USA)
About this entry
Cite this entry
Choudhury, E., Almarzouqi, S.J., Morgan, M.L., Lee, A.G. (2015). Acetazolamide for Pseudotumor Cerebri. In: Schmidt-Erfurth, U., Kohnen, T. (eds) Encyclopedia of Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35951-4_1144-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-35951-4_1144-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-35951-4
eBook Packages: Springer Reference MedicineReference Module Medicine